Germany Dermal Fillers Market 2022-2028

Germany Dermal Fillers Market 2022-2028

The Germany dermal filler market is projected to reach $352 million in 2028 from $226 million in 2021, growing at a CAGR of 6.6% during the forecast period (2022-2028). The market is driven by the growing cosmetic procedures, rising middle-aged population, and increasing disposable income in the country. Further, the growing minimally invasive procedure has increased the number of cosmetic procedures such as face-lifts, lip treatment, and enhancement, facial line correction treatment, and other treatments such as acne and scar treatment as the minimally invasive procedure provide quick recovery and better cosmetic results which are contributing to the market growth.

Here are a few key factors that have contributed to the market growth during the forecast period-

● The rise in the number of cosmetic procedures

● Demand for a minimally invasive cosmetic procedure

● Increase in R&D initiatives

● Increase in the aging population

HA fillers held the highest market share of 86.8% in 2021 owing to the increasing adoption of HA fillers for face-lift, lip treatment and enhancement, facial line correction treatment, and other treatments. There were around 284,000 HA-based minimally invasive cosmetic procedures performed in Germany in 2021. The market value for the HA filler segment was $196.2 million in 2021 and is estimated to reach $313.2 million in 2028, growing at the highest CAGR of 7.0% during the forecast period. Collagen fillers, PLLA, CaHA, and other dermal fillers held the least market share of 13.2% in 2021 owing to the increasing adoption of HA dermal fillers alternative. Various manufacturers such as Allergan PLC, Merz Pharmaceuticals GmbH, and Galderma Laboratories; among others have been offering branded products such as Captique, Esthélis, Elevess, Hylaform, Juvéderm, Perlane, Prevelle, Puragen, and Restylane for HA dermal fillers. PLLA is estimated to grow at the fastest CAGR of 7.2% during the forecast period. It was valued at $4.5 million in 2021, which is further estimated to reach $7.3 million in 2028. Galderma is working on PLLA dermal fillers owing to its collagen stimulator abilities that enable to gradually restorative the fullness of facial folds and wrinkles.

Based on application, the market is segmented into face-lift, lip treatment/enhancement, facial line correction treatment, and others. Other segments include acne scar treatment. Face-lift held the majority of the market share in the Germany dermal filler market in 2021. This is due to the increasing adoption of face-lift surgery procedures among the people in Germany. This is due to the rising trend of cosmetic surgery procedures among the middle-aged population to give a youthful appearance. The face-lift segment contributed 48.0% in market share in 2021 which is further estimated to reach 48.7% in 2028, estimated to account for $171.4 million in market value by 2028. Moreover, the lip treatment/enhancement segment is anticipated to register the highest growth rate of 7.0% over the forecast period. The segment has a market share of 27.0% in 2021. The growth is attributed to the significant adoption of HA in lip treatment/enhancement applications.

Based on end-user, the market is segmented into dermatology clinics and hospitals. Among these, dermatology clinics are estimated to contribute the highest with a market share of 68.5% in 2021 which accounted for $154.8 million. This share is further estimated to reach 71.0% in 2028, growing at a CAGR of 7.1% over the forecast period. The highest growth of the segment is due to the growing number of dermatology clinics. The growth of the dermatology clinics in the dermal fillers market is backed by the rising number of dermatology clinics. This is due to the rising trend of cosmetic surgery procedures among the middle-aged population to give a youthful appearance. Hospitals are another significant end-user of dermal fillers. Moreover, the hospital segment is followed by dermatology clinics with a total market share of 31.5% in 2021. The dermal fillers in the hospital market are projected to reach $102.3 million in 2028 from $71.2 million in 2021, by exhibiting a CAGR of 5.4% during the forecast period.

Various manufacturers such as Allergan PLC, Merz Pharmaceuticals GmbH, and Galderma Laboratories; among others have been offering branded products such as Captique, Esthélis, Elevess, Hylaform, Juvéderm, Perlane, Prevelle, Puragen, and Restylane for HA dermal fillers. These three players generated around 80% of the market share in 2021. This share is further expected to increase in the near future if the companies continue to cope with internal and external factors affecting their growth in a particular segment. Moreover, the players operating in the market are eying on strengthening their market position to afloat and sustain profitability in the market. These market players are adopting various strategies to capitalize on market opportunities. Mergers and acquisitions, new product launches, geographical expansion, partnerships, and collaborations are some of the key strategies adopted by the market players to stay competitive.